High-flow nasal oxygen versus noninvasive ventilation in acute respiratory failure: reflections on the RENOVATE trial
- PMID: 41816473
- PMCID: PMC12972756
- DOI: 10.21037/jtd-2025-1940
High-flow nasal oxygen versus noninvasive ventilation in acute respiratory failure: reflections on the RENOVATE trial
Keywords: RENOVTE; critical care; high-flow nasal oxygen (HFNO); noninvasive ventilation (NIV); resuscitation.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-1940/coif). A.B. is a medical consultant for Verathon, Inc. and BD. He has investment in Powerful Medical., Inc. B.J.W. has received honorarium to participate and lecture on critical care topics. He has also invested in a company that is developing an app that uses AI to interpret ECGs. Neither is relevant to this topic. The other author has no conflicts of interest to declare.
Comment on
-
High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.JAMA. 2025 Mar 11;333(10):875-890. doi: 10.1001/jama.2024.26244. JAMA. 2025. PMID: 39657981 Free PMC article. Clinical Trial.
References
-
- Tan D, Wang B, Cao P, et al. High flow nasal cannula oxygen therapy versus non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: a randomized controlled non-inferiority trial. Crit Care 2024;28:250. 10.1186/s13054-024-05040-9 - DOI - PMC - PubMed
-
- Yamane DP, Jones CW, Wilkerson RG, et al. High-velocity nasal insufflation versus noninvasive positive pressure ventilation for moderate acute exacerbation of chronic obstructive pulmonary disease in the emergency department: A randomized clinical trial. Acad Emerg Med 2025;32:403-13. 10.1111/acem.15038 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources